Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

rqsolutions medical devices distribution support - 35310 - orthodontic appliance, retainer - the surecure orthodontic aligner system is indicated for the treatment of tooth malocclusion in patients with permanent dentition. the aligner system repositions teeth by way of continuous gentle force.

Armenia - Inggeris - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

advance pharma gmbh - pantoprazole (pantoprazole sodium sesquihydrate) - tablets gastro-resistant - 20mg

Singapura - Inggeris - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 6 l1 protein - solution, sterile - 40 mcg - human papillomavirus type 11 l1 protein 40 mcg; human papillomavirus type 16 l1 protein 40 mcg; human papillomavirus type 18 l1 protein 20 mcg; human papillomavirus type 6 l1 protein 20 mcg

Singapura - Inggeris - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - human papillomavirus type 11 l1 protein; human papillomavirus type 16 l1 protein; human papillomavirus type 18 l1 protein; human papillomavirus type 6 l1 protein - solution, sterile - 40 mcg - human papillomavirus type 11 l1 protein 40 mcg; human papillomavirus type 16 l1 protein 40 mcg; human papillomavirus type 18 l1 protein 20 mcg; human papillomavirus type 6 l1 protein 20 mcg

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - brexucabtagene autoleucel, quantity: 1000000 cells/kg - injection, intravenous infusion - excipient ingredients: albumin; dimethyl sulfoxide; sodium chloride - cellular therapies - tecartus is a genetically modified autologous immunocellular therapy for the treatment of patients with relapsed or refractory mantle cell lymphoma (mcl), who have received two or more lines of therapy, including a btk inhibitor, unless ineligible or intolerant to treatment with a btk inhibitor.

Singapura - Inggeris - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - paroxetine hcl hemihydrate 14.25mg equv. to paroxetin hcl - tablet, extended release - 12.5 mg - paroxetine hcl hemihydrate 14.25mg equv. to paroxetin hcl 12.5 mg

Singapura - Inggeris - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - paroxetine hcl hemihydrate 28.51mg equv. to paroxetin hcl - tablet, extended release - 25mg - paroxetine hcl hemihydrate 28.51mg equv. to paroxetin hcl 25mg

Singapura - Inggeris - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - paroxetine hydrochloride hemihydrate 22.8 mg eqv paroxetine - tablet, film coated - 20 mg - paroxetine hydrochloride hemihydrate 22.8 mg eqv paroxetine 20 mg

Israel - Inggeris - Ministry of Health

glaxo smith kline (israel) ltd - paroxetine as hydrochloride - coated tablets - paroxetine as hydrochloride 20 mg - paroxetine - treatment of (in adults):­ major depressive disorder ­ obsessive compulsive disorder (ocd)­ panic disorder with and without agoraphobia­ social anxiety disorders/social phobia­ generalised anxiety disorder­ post-traumatic stress disorder